U.S. Electric Utilities Stock News

Wondering if Insight Enterprises is a beaten down opportunity or a value trap at today’s price? You are not the only one asking whether the current share price really reflects its underlying business. The stock has slid to around $79.62, with returns of about -6.3% over the last week, -11.6% over the last month, and a much steeper -46.7% year to date and -48.9% over the past year. This has reshaped how the market is pricing its future. Much of this shift has come as investors reassess IT...

If you are wondering whether Dropbox is quietly turning into a value opportunity while many investors focus on flashier tech names, this breakdown is for you. The stock is down 2.8% over the last week, 5.8% over the last month, and 3.3% year to date, but it is still up 27.7% over three years and 15.0% over five years, which tells a very different longer term story. Recent headlines have focused on Dropbox sharpening its product focus and pushing harder into AI driven features and workflow...

If you have been wondering whether Corcept Therapeutics is still worth buying after its big run, you are not alone; this stock has quietly turned into one of the more intriguing valuation stories in biotech. The share price now sits around $81.12, with a 7.4% gain over the last month, a hefty 62.3% year to date, and a 295.3% return over three years that has clearly shifted how the market prices its future. Recent headlines have focused on Corcept's expanding clinical pipeline and regulatory...

Gaming and Leisure Properties, Inc. recently appointed Michael Borofsky as a new independent director, expanding its board to eight members, seven of whom meet Nasdaq independence standards. Borofsky’s background in capital allocation, gaming investments, and complex transactions could influence how Gaming and Leisure Properties evaluates future deals, risk, and long-term capital deployment. Next, we’ll examine how adding Borofsky’s private equity and gaming experience to the board may...

AllianceBernstein Holding (AB) has been quietly grinding higher, with the stock up about 4% over the past 3 months and roughly 23% over the past year, outpacing many traditional asset managers. See our latest analysis for AllianceBernstein Holding. With the share price now around $39.85 and a 30 day share price return of 1.30 percent, the steadier 1 year total shareholder return of 22.82 percent suggests momentum is still building rather than fading. If you are weighing up where else...

In December 2025, Teva Pharmaceutical Industries obtained lender consent to extend the maturity of its senior unsecured sustainability-linked revolving credit facility from April 29, 2027, to April 29, 2028, while resetting key leverage and interest-cover covenants tied to potential Investment Grade Status. This covenant flexibility, together with recent progress in higher-margin branded and biosimilar products, gives Teva more room to align its balance sheet with its ongoing business...

Par Pacific Holdings (PARR) has been on a wild ride lately, slipping over the past week and month but still showing strong gains this year. This naturally raises questions about what is really driving the stock. See our latest analysis for Par Pacific Holdings. After such a strong run, with the share price now at $38.95 and a year to date share price return above 130 percent, the recent pullback looks more like momentum cooling than a complete change in the long term story. This is especially...

Wondering if Crown Holdings at around $101.53 is still a smart buy or if most of the upside has already been priced in? Here is a closer look at what the current share price really implies about its value. The stock has climbed 7.8% over the last week, 4.5% over the past month, and is up 25.0% year to date, adding to a 20.2% gain over the last year that has many investors taking a fresh look. Some of this momentum reflects renewed interest in packaging names as investors rotate toward...

Penske Automotive Group (PAG) has quietly added to recent gains, with the stock up about 6% over the past month even as its performance over the past 3 months remains slightly negative. See our latest analysis for Penske Automotive Group. Zooming out, Penske’s roughly 12% year to date share price return and strong multi year total shareholder returns suggest momentum has cooled recently, but the longer term trend still reflects solid value creation as investors reassess growth and cyclicality...

In the past quarter, Collegium Pharmaceutical reported a strong Q3, with revenue rising 31.4% year on year and topping analyst expectations by 10.7%, driven by its differentiated pain management medicines. The company also exceeded its full-year revenue guidance, signaling operational strength that reinforces its focus on specialty products for chronic pain. With Q3 revenue surpassing expectations by 10.7%, we’ll now examine how this performance influences Collegium’s existing investment...

Wondering if Exxon Mobil is still a buy after its huge run over the last few years, or if the easy money has already been made? You are not alone. Despite a 240.2% gain over 5 years and a solid 10.1% return over the last year, the stock has cooled recently, slipping 3.0% over the past week and 3.9% over the last month, while still up 6.9% year to date. Recent moves have been shaped by shifting expectations for long term oil and gas demand and renewed focus on energy security, as markets...

Wondering if Huntington Ingalls Industries is still a smart buy after its big run, or if the market has already priced in the upside? This breakdown will walk through what the current share price really implies. The stock has climbed to around $326.80, with gains of 3.8% over the last week, 4.1% over the last month, and 74.2% year to date, building on a 72.9% 1-year return and 123.6% over 5 years that has clearly shifted how investors see its prospects and risks. That re-rating has been...

Crocs (CROX) has quietly staged a comeback, with shares up roughly 25% over the past month and about 14% in the past 3 months, despite flat revenue and volatile long term returns. See our latest analysis for Crocs. Zooming out, that strong 1 month share price return contrasts with a negative year to date share price return and a weak 1 year total shareholder return, hinting that sentiment may be turning after a choppy stretch. If Crocs has you rethinking where growth might show up next in...

If you are wondering whether Centene is a beaten down bargain or a value trap at current prices, this article will walk through what the numbers are really saying about the stock. Despite being down 35.6% year to date and 32.6% over the past year, the share price has shown some recent stability, with a 2.3% gain over the last week and 7.1% over the last month. Much of the recent price action has been shaped by shifting expectations around US healthcare policy and Medicaid redeterminations,...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

The board of The Toro Company ( NYSE:TTC ) has announced that it will be paying its dividend of $0.39 on the 12th of...

Some CME Group Inc. ( NASDAQ:CME ) shareholders may be a little concerned to see that the Chairman & CEO, Terrence...

Some The Carlyle Group Inc. ( NASDAQ:CG ) shareholders may be a little concerned to see that the Co-Founder...

Wondering if monday.com is starting to look like a bargain after its slide, or if the market is signaling deeper concerns about the business. The stock is down 7.6% over the last week, 6.5% over the past month, and a steep 35.0% year to date, extending a 40.4% drop over the last year despite still being up 29.5% over three years. Much of this volatility has been driven by shifting sentiment toward high growth software names as interest rate expectations change, with investors rotating in and...

HCI Group recently reported that its core homeowners insurance operations have grown rapidly over the past two years, with net premiums earned rising about 28% annually as it applies proprietary technology to underwriting and claims. Analysts now expect book value per share to increase by about 36.9% over the coming 12 months, highlighting how HCI’s capital generation and balance sheet strength are being reinforced by this operating momentum. We’ll now consider how this acceleration in net...

Morgan Stanley previously downgraded HCA Healthcare from Equalweight to Underweight, and HCA later announced a senior notes offering to help refinance borrowings and support general corporate needs. A large institutional holder, L1 Capital International Fund, has also reduced its position after strong share price appreciation, signalling a reassessment of risk‑reward at current levels. Next, we’ll examine how concerns about potentially easing government healthcare tailwinds could reshape HCA...

If you are wondering whether Symbotic is still worth considering after its huge run, or if you are late to the party, this breakdown will help you figure out what the current price is really asking you to believe. The stock has climbed about 0.8% over the last week and 7.8% over the last month, but the real eye catchers are its 153.7% year to date and 145.6% 1 year returns, on top of a 408.8% gain over 3 years. Recent headlines have focused on Symbotic's expanding automation partnerships and...

Wondering if Hecla Mining is still a bargain after its huge run, or if you are turning up late to the party? This breakdown will help you make sense of what the current share price really implies. The stock has surged recently, climbing 11.9% over the last week, 30.3% over the past month, and an eye catching 261.6% year to date. This has completely changed how the market is thinking about its risk and reward profile. That kind of move has been underpinned by a stronger silver price backdrop...

Canaan (NasdaqGM:CAN) has been quietly grinding through a tough stretch, with the stock down sharply this year even as annual revenue and net income growth have swung higher off a low base. See our latest analysis for Canaan. Still, the 1 year to date share price return of negative 64.23 percent and 1 year total shareholder return of negative 73.27 percent show that sentiment has been deteriorating rather than stabilising, as investors continue to price in execution and crypto cycle risks. If...